Investigación / Grupos de investigación

Grupo  2

Enfermedades Neurológicas

Publicaciones (386)

  • Sabin, J; Urtiaga, S; Pilo, B; Thuissard, I; Galan, V; de la Maza, SS; Costa-Frossard, L; Gomez-Moreno, M; Diaz-Diaz, J; Oreja-Guevara, C; Martinez-Gines, ML; Lozano, A; Borrega, L; Ayuso, L; Castro, A; Sanchez, P; Meca-Lallana, V; Munoz, C; Casanova, I; de Silanes, CL; Martin, H; Rodriguez-Garcia, E; Moreno, I; Garcia-Merino, JA; Aladro, Y.

    Tolerability and safety of dimethyl fumarate in relapsing multiple sclerosis: a prospective observational multicenter study in a real-life Spanish population

    JOURNAL OF NEUROLOGY. 2020; 267(8): 2362-2371 Nº de citas: 19 [doi:10.1007/s00415-020-09848-7]

  • Martinez-Maldonado, A; Jurado-Barba, R; Sion, A; Dominguez-Centeno, I; Castillo-Parra, G; Prieto-Montalvo, J; Rubio, G.

    Brain functional connectivity after cognitive-bias modification and behavioral changes in abstinent alcohol-use disorder patients

    INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY. 2020; 154: 46-58 Nº de citas: 8 [doi:10.1016/j.ijpsycho.2019.10.004]

  • Jurado-Barba, R; Sion, A; Martinez-Maldonado, A; Dominguez-Centeno, I; Prieto-Montalvo, J; Navarrete, F; Garcia-Gutierrez, MS; Manzanares, J; Rubio, G.

    Neuropsychophysiological Measures of Alcohol Dependence: Can We Use EEG in the Clinical Assessment?

    Frontiers in Psychiatry. 2020; 11: Nº de citas: 13 [doi:10.3389/fpsyt.2020.00676]

  • Cuello, JP; Martínez Ginés ML; Tejeda-Velarde, A; Medina Heras S; García Domínguez JM; Fernández Velasco JI; Lozano Ros A; Higueras, Y; Meldaña Rivera A; Goicochea Briceño H; Garcia-Tizon Larroca S; De Leon-Luis, J; de Andres, C; Álvarez Lafuente R; Villar, LM.

    Cytokine profile during pregnancy predicts relapses during pregnancy and postpartum in multiple sclerosis

    JOURNAL OF THE NEUROLOGICAL SCIENCES. 2020; 414: 116811-116811 Nº de citas: 8 [doi:10.1016/j.jns.2020.116811]

  • Manzano, S; Aguera, L; Aguilar, M; Olazaran, J.

    A Review on Tramiprosate (Homotaurine) in Alzheimer's Disease and Other Neurocognitive Disorders

    Frontiers in Neurology. 2020; 11: Nº de citas: 61 [doi:10.3389/fneur.2020.00614]

  • Grandas, F; Traba, A; Perez-Sanchez, JR; Esteban, A.

    Pretarsal blepharospasm: Clinical and electromyographic characteristics

    CLINICAL NEUROPHYSIOLOGY. 2020; 131(7): 1678-1685 Nº de citas: 7 [doi:10.1016/j.clinph.2020.03.016]

  • Garcia-Romero, N; Palacin-Aliana, I; Madurga, R; Carrion-Nayarro, J; Esteban-Rubio, S; Jimenez, B; Collazo, A; Perez-Rodriguez, F; de Mendivil, AO; Fernandez-Carballal, C; Garcia-Duque, S; Diamantopoulos-Fernandez, J; Belda-Iniesta, C; Prat-Acin, R; Sanchez-Gomez, P; Calvo, E; Ayuso-Sacido, A.

    Bevacizumab dose adjustment to improve clinical outcomes of glioblastoma

    BMC MEDICINE. 2020; 18(1): Nº de citas: 29 [doi:10.1186/s12916-020-01610-0]

  • Fernandez, O; Aladro, Y; Arroyo, R; Brieva, L; Calles-Hernandez, MC; Carrascal, P; Comabella, M; Costa-Frossard, L; Eichau, S; Garcia-Merino, JA; Ginestal, R; Gonzalez, I; Izquierdo, G; Martinez-Gines, ML; Meca-Lallana, JE; Mendibe-Bilbao, MD; Oterino, A; Prieto, JM; Rio, J; Ramio-Torrenta, L; Romero-Pinel, L; Tellez, N; Rodriguez-Antiguedad, A.

    12th Post-ECTRIMS Meeting: review of the novelties from the 2019 ECTRIMS Congress (II)

    REVISTA DE NEUROLOGIA. 2020; 70(11): 417-428 Nº de citas: 3 [doi:10.33588/rn.7011.2020122]

  • Maurino, J; Martinez-Gines, ML; Garcia-Dominguez, JM; Solar, MD; Carcelen-Gadea, M; Ares-Luque, A; Ballabriga, J; Navarro-Canto, L; Medrano, N; Honan, CA; W-IMPACT Study Grp.

    Workplace difficulties, health-related quality of life, and perception of stigma from the perspective of patients with Multiple Sclerosis

    Multiple Sclerosis and Related Disorders. 2020; 41: Nº de citas: 36 [doi:10.1016/j.msard.2020.102046]

  • Massot-Tarrus, A; White, KP; Mousavi, SR; Hayman-Abello, S; Hayman-Abello, B; Mirsattari, SM.

    Concordance between fMRI and Wada test for memory lateralization in temporal lobe epilepsy: A meta -analysis and systematic review

    EPILEPSY & BEHAVIOR. 2020; 107: Nº de citas: 12 [doi:10.1016/j.yebeh.2020.107065]

  • Fernandez, O; Aladro, Y; Arroyo, R; Brieva, L; Calles-Hernandez, MC; Carrascal, P; Comabella, M; Costa-Frossard, L; Eichau, S; Garcia-Merino, JA; Ginestal, R; Gonzalez, I; Izguierdo, G; Martinez-Gines, ML; Meca-Lallana, JE; Mendibe-Bilbao, MD; Oterino, A; Prieto, JM; Rio, J; Ramio-Torrenta, L; Romero-Pinel, L; Tellez, N; Rodriguez-Antiguedad, A.

    12th Post-ECTRIMS Meeting: review of the novelties from the 2019 ECTRIMS Congress (I)

    REVISTA DE NEUROLOGIA. 2020; 70(10): 379-389 Nº de citas: 2 [doi:10.33588/rn.7010.2020121]

  • Postigo, A; Bermejo, J; Munoz, P; Valerio, M; Marin, M; Pinilla, B; Cuerpo, G; Mari, A; Delgado-Montero, A; Bouza, E; Fernandez-Aviles, F; Martinez-Selles, M.

    Troponin elevation is very common in patients with infective endocarditis and is associated with a poor outcome

    INTERNATIONAL JOURNAL OF CARDIOLOGY. 2020; 307: 82-86 Nº de citas: 4

  • Costa-Frossard, L; Moreno-Torres, I; Meca-Lallana, V; Garcia-Dominguez, JM; Grp Estudio Enfermedades Desmielin.

    EMCAM (Multiple Sclerosis Autonomous Community of Madrid) document for the management of patients with multiple sclerosis during the SARS-CoV-2 pandemic

    REVISTA DE NEUROLOGIA. 2020; 70(9): 329-340 Nº de citas: 11 [doi:10.33588/rn.7009.2020155]

  • Malhotra, S; Costa, C; Eixarch, H; Keller, CW; Amman, L; Martinez-Banaclocha, H; Midaglia, L; Sarro, E; Machin-Diaz, I; Villar, LM; Trivino, JC; Oliver-Martos, B; Parlade, LN; Calvo-Barreiro, L; Matesanz, F; Vandenbroeck, K; Urcelay, E; Martinez-Gines, ML; Tejeda-Velarde, A; Fissolo, N; Castillo, J; Sanchez, A; Robertson, AAB; Clemente, D; Prinz, M; Pelegrin, P; Lunemann, JD; Espejo, C; Montalban, X; Comabella, M.

    NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients

    BRAIN. 2020; 143: 1414-1430 Nº de citas: 111 [doi:10.1093/brain/awaa084]

  • Barrero, F; Mallada-Frechin, J; Martinez-Gines, ML; Marzo, ME; Meca-Lallana, V; Izquierdo, G; Ara, JR; Oreja-Guevare, C; Meca-Lallana, J; Forero, L; Sanchez-Veram, I; Moreno, MJ.

    Spanish real-world experience with fingolimod in relapsing-remitting multiple sclerosis patients: MS NEXT study

    PLoS One. 2020; 15(4): Nº de citas: 8 [doi:10.1371/journal.pone.0230846]

  • Cuello, JP; Camara, PS; Dominguez, JMG; Ros, AL; Serrano, MM; Gines, MLM.

    Pregnancy exposure to disease-modifying drugs in multiple sclerosis: a prospective study

    MEDICINA CLINICA. 2020; 154(6): 214-217 Nº de citas: 2 [doi:10.1016/j.medcli.2019.05.026]

  • Fernandez, O; Costa-Frossard, L; Martinez-Gines, M; Montero, P; Prieto, JM; Ramio, L.

    The Broad Concept of "Spasticity-Plus Syndrome" in Multiple Sclerosis: A Possible New Concept in the Management of Multiple Sclerosis Symptoms

    Frontiers in Neurology. 2020; 11: Nº de citas: 32 [doi:10.3389/fneur.2020.00152]

  • Pagonabarraga, J; Arbelo, JM; Grandas, F; Luquin, MR; Martin, PM; Rodriguez-Oroz, MC; Valldeoriola, F; Kulisevsky, J.

    A Spanish Consensus on the Use of Safinamide for Parkinson's Disease in Clinical Practice

    Brain Sciences. 2020; 10(3): Nº de citas: 7 [doi:10.3390/brainsci10030176]